Moore Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-12,500
Closed -$260K 304
2018
Q4
$260K Buy
+12,500
New +$260K 0.01% 194